STOCK TITAN

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good’ Webinar on Tuesday, November 19

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
AI

Ekso Bionics announced that Katherine Strausser, Principal Controls Engineer, will participate in an 'AI for Good' webinar titled 'AI-powered Exoskeletons Revolutionizing Rehabilitation and Mobility' on Tuesday, November 19 at 10:00 a.m. ET. The session will explore latest exoskeleton technologies and challenges in medical rehabilitation. Katherine, who holds a Ph.D. in Mechanical Engineering and is one of the original inventors of the EksoNR device, specializes in controls systems for robotics and human-exoskeleton interaction.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-4.44% News Effect

On the day this news was published, EKSO declined 4.44%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Katherine Strausser, Principal Controls Engineer at Ekso Bionics, will be participating in an ‘AI for Good’ webinar.

The webinar, entitled “AI-powered Exoskeletons Revolutionizing Rehabilitation and Mobility”, will take place on Tuesday, November 19 at 10:00 a.m. ET. The session will explore the latest exoskeleton technologies and challenges, illustrating how these technologies are not just assisting in overcoming physical limitations but are paving the way for a new era in medical rehabilitation. To register for the webinar, click here.

Katherine holds a Ph.D. in Mechanical Engineering and a master’s degree from the University of California at Berkeley, and a bachelor’s degree from Carnegie Mellon University. As one of the original inventors of the EksoNR device, Katherine primarily focuses on controls systems for robotics and the interaction of humans with exoskeleton devices.

About Ekso Bionics® 
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.

Contact:
David Carey
212-867-1768
investors@eksobionics.com


FAQ

When is Ekso Bionics (EKSO) participating in the AI for Good webinar?

Ekso Bionics is participating in the AI for Good webinar on Tuesday, November 19 at 10:00 a.m. ET.

What is the topic of Ekso Bionics' (EKSO) AI for Good webinar?

The webinar is titled 'AI-powered Exoskeletons Revolutionizing Rehabilitation and Mobility' and will explore the latest exoskeleton technologies and challenges in medical rehabilitation.

Who is representing Ekso Bionics (EKSO) at the AI for Good webinar?

Katherine Strausser, Principal Controls Engineer and one of the original inventors of the EksoNR device, will represent Ekso Bionics at the webinar.
Ekso Bionics

NASDAQ:EKSO

EKSO Rankings

EKSO Latest News

EKSO Latest SEC Filings

EKSO Stock Data

14.35M
3.17M
4.95%
2.75%
5.14%
Medical Instruments & Supplies
General Industrial Machinery & Equipment, Nec
Link
United States
SAN RAFAEL